AKESO: CONNECTED TRANSACTION FURTHER INFORMATION IN RELATION TO ACQUISITION OF EQUITY INTEREST IN AD PHARMACEUTICALS
Mar 4 07:35 ET
AKESO: CONNECTED TRANSACTION IN RELATION TO ACQUISITION OF EQUITY INTEREST IN AD PHARMACEUTICALS
Feb 8 18:30 ET
AKESO, INC. - B: CONTINUING CONNECTED TRANSACTIONS WITH CHIA TAI TIANQING IN RELATION TO PHASE III REGISTRATION TRIAL OF PENPULIMAB (PD-1 MONOCLONAL ANTIBODY, AK105) FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA MASTER MATERIALS AND SERVICES PROCUREMENT AG
Sep 20, 2022 10:12 ET
AKESO, INC. - B: CONTINUING CONNECTED TRANSACTIONS FURTHER INFORMATION IN RELATION TO EXCLUSIVE SALES AGREEMENT OF PENPULIMAB MONOCLONAL ANTIBODY
Jan 30, 2022 17:10 ET
AKESO, INC. - B: CONTINUING CONNECTED TRANSACTIONS EXCLUSIVE SALES AGREEMENT OF PENPULIMAB MONOCLONAL ANTIBODY
Dec 20, 2021 06:56 ET
No Data
No Data